Message for the BOD2 Oct 2021 14:42
Saturday thoughts.
Mr Rees, Hextall, Reynolds & Co, for 2022 and beyond could you address a few of the following issues.
1) Reduce the size of the board (Seems far to big for the size of the company)
2) Be more careful throwing around share options. ( Seems like these share options are far to easy come by).
3) Stop share dilution (In my short time here the company has doubled the amount of shares in circulation).
4) Think more of PI’s not just yourselves (we’ve invested in good faith but still not seeing the rewards).
5) Encourage board members to purchase some shares at the current market price (don’t see this happening very often, take a look at Cathel Friel Open Orphan he’s recently invested 2 years salary into the company buying at full market price).
Obviously most of my points will be raised by the institutions whenever the meeting takes place, the instis are people just like us who expect a return on investment.
Finally a question for what it’s worth.
Q) In 2019 you talked about listing on the NASDAQ and aimed to build Yourgene to a £500 million MCap, I believe you said within 2 to 3 years, can I now assume that neither will happen ?.